Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SleepRes develops innovative respiratory care solutions for obstructive sleep apnea. Its flagship KPAP™ technology uses a novel pressure algorithm to reduce inspiratory pressure while maintaining therapeutic efficacy, aiming to improve comfort and adherence compared to traditional CPAP. Clinical studies show that KPAP achieves similar effectiveness as standard CPAP with greater patient comfort. The company also markets V-Com™, an FDA-cleared accessory that softens peak inspiratory flow on PAP devices to help new or struggling patients adapt more easily to therapy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SleepRes.